cirsimaritin has been researched along with 3,7-dihydroxyflavone in 1 studies
Studies (cirsimaritin) | Trials (cirsimaritin) | Recent Studies (post-2010) (cirsimaritin) | Studies (3,7-dihydroxyflavone) | Trials (3,7-dihydroxyflavone) | Recent Studies (post-2010) (3,7-dihydroxyflavone) |
---|---|---|---|---|---|
49 | 0 | 21 | 20 | 0 | 10 |
Protein | Taxonomy | cirsimaritin (IC50) | 3,7-dihydroxyflavone (IC50) |
---|---|---|---|
Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | 4.6 | |
Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brun, R; Lack, G; Perozzo, R; RĂ¼edi, P; Scapozza, L; Tasdemir, D | 1 |
1 other study(ies) available for cirsimaritin and 3,7-dihydroxyflavone
Article | Year |
---|---|
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase; Alcohol Oxidoreductases; Animals; Antimalarials; Catechin; Cells, Cultured; Chloroquine; Drug Resistance; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Fatty Acids; Flavones; Flavonoids; Humans; Hydro-Lyases; Kinetics; Luteolin; Phenols; Plasmodium falciparum; Polyphenols; Structure-Activity Relationship | 2006 |